Skip to content

Non-Invasive Stimulation for Improving Motor Function

Non-Invasive Stimulation for Improving Motor Function in Spinal Cord Injury

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03592173
Enrollment
30
Registered
2018-07-19
Start date
2013-07-31
Completion date
2025-12-31
Last updated
2024-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

The purpose of this study is to determine if spinal excitability is increased with a Spinal Associative Stimulation (SAS) protocol, and to determine the functional consequences of this technique on motor recovery.

Detailed description

Recovery of motor function continues to be a problem following Spinal Cord Injury. Non-invasive brain stimulation techniques, targeting cortical areas, have been shown to enhance the excitability in the human motor cortex, and these changes in the motor cortex may be of significance for the rehabilitation of brain injured patients. However, little is known about the adaptational changes in the excitability/plasticity of spinal neural circuits in spinal cord injury patients. The purpose of this study is to investigate the excitability of cortical and spinal inhibitory and excitatory mechanisms before and following a period of repetitive and synchronized dual peripheral nerve and brain stimulation. Repetitive, paired brain and peripheral nerve stimulation as a neuromodulatory tool, paired associative stimulation (PAS), has been well described. In this technique, stimuli are timed such that afferent and efferent volleys interact at the level of the cortex, that lead to a temporary enhancement of Motor Evoked Potential (MEP) amplitude in target muscles, and when applied repeatedly, lead to a sustained effect, outlasting the intervention period. This repetitive technique has been done in healthy subjects and patients with neurological diseases. By modifying the time between paired stimuli, the investigators will generate afferent/efferent interactions in the spinal cord. The working hypothesis of this study is that the acute facilitation of the H-reflex during Paired TMS and peripheral nerve stimulation, may be harnessed to modulate spinal excitability (sustained increase in the MEP amplitude). That is, the investigators will test if similar to PAS, a change in excitability outlasting the stimulation/intervention period may occur with afferent/efferent interactions, although at the level of the spinal cord rather than the cortex, and be useful to strengthen residual pathways after damage to the spinal cord.

Interventions

DIAGNOSTIC_TESTPaired TMS & Peripheral Nerve Stimulation

Method of assessing neurophysiology and activity of the spinal cord

Sponsors

Burke Medical Research Institute
CollaboratorOTHER
Kathleen Friel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Thirty chronic SCI participants will given the SAS intervention and a control intervention in a randomized cross-over study, with at least one week between interventions. Each patient will be required to attend the Burke Medical Research Institute on three occasions. We will use a within-subjects design, to test changes in neurophysiologic and voluntary measures after intervention with respect to baseline.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Spinal cord injury subjects with chronic lesions (\> 6 months after the injury) * Motor incomplete lesion, measured by the American Spinal cord Injury Association (ASIA) Impairment Scale (AIS) * Traumatic cause of lesion; d) Some degree of motor function in the ankle flexor and extensors (Low extremity Motor Score - LEMS≥3).

Exclusion criteria

* Motor and sensory complete lesion (AIS A); LEMS \< 3; * Non-traumatic cause of lesion * Medically unstable condition * Other concurrent neurological illness * Presence of a potential TMS risk factor (detailed below) Potential TMS risk factor: * Damaged skin at the site of stimulation * Presence of an electrically, magnetically or mechanically activated implant * An intracerebral vascular clip, or any other electrically sensitive support system * Metal in any part of the body, including metal injury to the eye * A history of medication-resistant epilepsy in the family * Past history of seizures or unexplained spells of loss of consciousness.

Design outcomes

Primary

MeasureTime frameDescription
Change in H-Reflex ThresholdBaseline compared with immediately after interventionAssessment of muscle reaction after stimulation of sensory fibers

Secondary

MeasureTime frameDescription
Lower Extremity Motor Score (LEMS)Baseline, immediately after interventionAssessment of lower extremity strength in key muscles; maximal score of 50 with 20 or less indicating participant likely has limited ambulation.
Walking Index for Spinal Cord Injury (WISCI II)Baseline, immediately after interventionThis is a functional capacity scale that rank orders ambulation in people with spinal cord injury, by evaluating the amount of physical assistance, braces or devices required to walk 10 meters. Rank scores range from 0-20. A higher score is indicative of more independent ambulation.
10 Meter Walk TestBaseline, immediately after interventionMeasure of gait speed
Spinal Cord Independence Measure, Version 3 (SCIM III)Baseline, immediately after interventionA disability rating scale developed to specifically address the ability of SCI patients to perform basic activities of daily living independently (including self-care, mobility, respiration and sphincter management)
Muscle ForceBaseline, immediately after interventionAmount of force recorded during maximal voluntary isometric contraction of a grip movement, recorded with a grip strength measurement device.
AnklebotBaseline, immediately after interventionLower extremity robotic device that provides kinematic evaluation data

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026